359 related articles for article (PubMed ID: 11753600)
21. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.
Annino L; Vegna ML; Camera A; Specchia G; Visani G; Fioritoni G; Ferrara F; Peta A; Ciolli S; Deplano W; Fabbiano F; Sica S; Di Raimondo F; Cascavilla N; Tabilio A; Leoni P; Invernizzi R; Baccarani M; Rotoli B; Amadori S; Mandelli F;
Blood; 2002 Feb; 99(3):863-71. PubMed ID: 11806988
[TBL] [Abstract][Full Text] [Related]
22. [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center].
Wang J; Jiang B; Liu K; Xu L; Zhang X; Chen H; Jia J; Yang S; Bao L; Jiang H; Lu J; Zhu H; Zhao T; Huang X; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):726-32. PubMed ID: 26462770
[TBL] [Abstract][Full Text] [Related]
23. [Treatment and Prognosis of Adult T Cell Acute Lymphoblastic Leukemia].
Huang ZF; Wang TY; Fu MW; Liu W; Hao M; Qiu LG; Zou H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):485-491. PubMed ID: 31484610
[TBL] [Abstract][Full Text] [Related]
24. Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
Hatta Y; Mizuta S; Matsuo K; Ohtake S; Iwanaga M; Sugiura I; Doki N; Kanamori H; Ueda Y; Yoshida C; Dobashi N; Maeda T; Yujiri T; Monma F; Ito Y; Hayakawa F; Takeuchi J; Kiyoi H; Miyazaki Y; Naoe T
Ann Hematol; 2018 Sep; 97(9):1535-1545. PubMed ID: 29694642
[TBL] [Abstract][Full Text] [Related]
25. Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
Zhang M; Fu H; Lai X; Tan Y; Zheng W; Shi J; Zhao Y; Lin M; He J; Cai Z; Luo Y; Huang H
PLoS One; 2016; 11(10):e0163599. PubMed ID: 27695097
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.
Yoshimura T; Nakane T; Hirose A; Koh H; Nakamae M; Aimoto M; Nishimoto M; Hayashi Y; Terada Y; Nakamae H; Hino M
Osaka City Med J; 2013 Jun; 59(1):9-21. PubMed ID: 23909077
[TBL] [Abstract][Full Text] [Related]
27. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
28. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
[TBL] [Abstract][Full Text] [Related]
29. Survival Rates of Adults With Acute Lymphoblastic Leukemia in a Low-Income Population: A Decade of Experience at a Single Institution in Mexico.
Jaime-Pérez JC; Jiménez-Castillo RA; Herrera-Garza JL; Gutiérrez-Aguirre H; Marfil-Rivera LJ; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):60-68. PubMed ID: 27600987
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors of adult Philadelphia chromosome negative acute lymphoblastic leukemia].
Wang J; Huang X; Jiang B; Jia J; Yang S; Bao L; Jiang H; Lu J; Zhu H; Zhao T; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):10-5. PubMed ID: 25641138
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
32. Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study.
Yaniv I; Krauss AC; Beohou E; Dalissier A; Corbacioglu S; Zecca M; Afanasyev BV; Berger M; Diaz MA; Kalwak K; Sedlacek P; Varotto S; Peters C; Bader P
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1629-1642. PubMed ID: 29548831
[TBL] [Abstract][Full Text] [Related]
33. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.
Oriol A; Vives S; Hernández-Rivas JM; Tormo M; Heras I; Rivas C; Bethencourt C; Moscardó F; Bueno J; Grande C; del Potro E; Guardia R; Brunet S; Bergua J; Bernal T; Moreno MJ; Calvo C; Bastida P; Feliu E; Ribera JM;
Haematologica; 2010 Apr; 95(4):589-96. PubMed ID: 20145276
[TBL] [Abstract][Full Text] [Related]
34. Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis.
Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH
Biol Blood Marrow Transplant; 2017 Jan; 23(1):96-102. PubMed ID: 27777140
[TBL] [Abstract][Full Text] [Related]
35. [Allogeneic hematopoietic stem cell transplantation for treatment of Philadelphia chromosome positive acute lymphoblastic leukemia].
Xu LP; Huang XJ; Liu KY; Chen H; Liu DH; Zhang YC; Chen YH; Han W; Gao ZY; Lu DP
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):231-5. PubMed ID: 15968308
[TBL] [Abstract][Full Text] [Related]
36. Acute lymphocytic leukemia in adults: a retrospective study and analysis of current management options.
Ho TC; Tefferi A; Su JQ; Litzow MR; Hoagland HC; Noël P
Mayo Clin Proc; 1994 Oct; 69(10):937-48. PubMed ID: 7934190
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00.
Bassan R; Rossi G; Pogliani EM; Di Bona E; Angelucci E; Cavattoni I; Lambertenghi-Deliliers G; Mannelli F; Levis A; Ciceri F; Mattei D; Borlenghi E; Terruzzi E; Borghero C; Romani C; Spinelli O; Tosi M; Oldani E; Intermesoli T; Rambaldi A
J Clin Oncol; 2010 Aug; 28(22):3644-52. PubMed ID: 20606084
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
